Clinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC)

AM Weppler, P Bhave, P De Ieso, M Chua, J Raleigh, A Hatzimihalis, A Gill, S Balachander, J Callahan, A Pattison, A Caneborg, G Au Yeung, G McArthur, RJ Hicks, R Tothill, SK Sandhu